Ian Taylor sold $151k of ARVN
President, R&D at ARVINAS, INC.. 9,020 shares at an average of $16.71, traded Feb 24, 2025, filed Feb 25, 2025.
Score components
- +20RolePresident
- +11Trade size$151k at market
- 0Share of holdings soldSold 5.4% of holdings
- +15Cluster4 insiders selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001655759-25-000050, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Feb 24, 2025 | SOpen-market sale Common Stock | -7,356 | $16.75 | $123k | 160,785 | Feb 25, 2025 |
| Feb 24, 2025 | SOpen-market sale Common Stock | -1,664 | $16.55 | $28k | 159,121 | Feb 25, 2025 |
Related signals
Other insiders at ARVINAS, INC. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 46Moderate | ARVNbuy ARVINAS, INC. | Briggs Morrison director | $227k 30,000 shares | +65% | |
| 36Weak | ARVINAS, INC. | Andrew Saik Chief Financial Officer | $43k 5,700 shares | -3% | |
| 23Weak | ARVINAS, INC. | Angela M Cacace Chief Scientific Officer | $19k 2,583 shares | -2% | |
| 23Weak | ARVNsell ARVINAS, INC. | Noah Berkowitz Chief Medical Officer | $74k 8,658 shares | -7% | |
| 58Moderate | ARVINAS, INC. | John G Houston President and CEO | $524k 31,338 shares | -3% | |
| 38Weak | ARVINAS, INC. | Angela M Cacace Chief Scientific Officer | $70k 4,207 shares | -4% | |
| 30Weak | ARVINAS, INC. | David K Loomis Chief Accounting Officer | $20k 1,214 shares | -6% | |
| 15Weak | ARVNsell ARVINAS, INC. | David K Loomis Chief Accounting Officer | $10k 460 shares | -5% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.